- $52.18bn
- $50.15bn
- $71.05bn
- 72
- 89
- 56
- 85
Annual balance sheet for Metlife, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-Q | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,614 | 2,210 | — | 3,561 | 3,528 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Deferred Policy Acquisition Costs | |||||
| Total Other Assets | |||||
| Total Assets | 795,146 | 759,708 | 663,072 | 687,584 | 677,457 |
| Accrued Expenses | |||||
| Policy Liabilities | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 720,588 | 692,226 | 633,191 | 657,569 | 650,012 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 74,558 | 67,482 | 29,881 | 30,015 | 27,445 |
| Total Liabilities & Shareholders' Equity | 795,146 | 759,708 | 663,072 | 687,584 | 677,457 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |